# EDGAR Filing Document

**Accession Number:** 0001638287
**File Stem:** 9999999995-23-000244
**Filing Date:** 2023-1
**Character Count:** 1394
**Document Hash:** 71672e7aaa75975e7cd0678623635d01
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-23-000244.hdr.sgml**: 20230201

**ACCESSION NUMBER**: 9999999995-23-000244

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230131

**DATE AS OF CHANGE**: 20230201

**EFFECTIVENESS DATE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NeuroBo Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001638287
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 472389984
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-269365
- **FILM NUMBER:** 23574598

**BUSINESS ADDRESS:**
- **STREET 1:** 200 BERKELEY ST.
- **STREET 2:** FL 19
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** (857) 702-9600

**MAIL ADDRESS:**
- **STREET 1:** 200 BERKELEY ST.
- **STREET 2:** FL 19
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Gemphire Therapeutics Inc.
- **DATE OF NAME CHANGE:** 20150331

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** January 31, 2023

**Time:** 17:30:00

**Form Type:** S-3

---

**CIK:** 0001638287

**Company Name:** NeuroBo Pharmaceuticals, Inc.

**File Number:** 333-269365